Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2024 Filed Aug 1, 2024 16:05 UTC |
ARWM Inc Pte. Ltd.10% owner
|
SaleClass A ordinary shares | 100,000 | $0.50 | $50,000.00 |
DisclosureSEC source: 0001437749-24-024288 · rdgdoc.xml · nonDerivative · entry 1 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,854,999 Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 20:06 UTC |
LeBlanc JeffDirector
|
PurchaseClass A ordinary shares | 100,000 | $0.50 | $50,000.00 |
DisclosureSEC source: 0001437749-24-024289 · rdgdoc.xml · nonDerivative · entry 1 LeBlanc Jeff · CIK 0001854467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Read SEC document |
| July 06, 2024 Filed Jul 17, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
SaleClass A ordinary shares | 30,000 | $0.50 | $15,000.00 |
DisclosureSEC source: 0001437749-24-022911 · rdgdoc.xml · nonDerivative · entry 1 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,954,999 Read SEC document |
| July 06, 2024 Filed Jul 29, 2024 16:02 UTC |
Ridgway Adam JohnDirector
|
PurchaseClass A ordinary shares | 30,000 | $0.50 | $15,000.00 |
DisclosureSEC source: 0001437749-24-023730 · rdgdoc.xml · nonDerivative · entry 1 Ridgway Adam John · CIK 0002025546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Read SEC document |
| June 14, 2024 Filed Jul 10, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
SaleClass A ordinary shares | 70,000 | $0.50 | $35,000.00 |
DisclosureSEC source: 0001437749-24-022464 · rdgdoc.xml · nonDerivative · entry 6 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,984,999 Read SEC document |
| June 14, 2024 Filed Jul 10, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
SaleClass A ordinary shares | 70,000 | $0.50 | $35,000.00 |
DisclosureSEC source: 0001437749-24-022464 · rdgdoc.xml · nonDerivative · entry 5 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,054,999 Read SEC document |
| June 14, 2024 Filed Jul 10, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
SaleClass A ordinary shares | 130,000 | $0.50 | $65,000.00 |
DisclosureSEC source: 0001437749-24-022464 · rdgdoc.xml · nonDerivative · entry 4 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,124,999 Read SEC document |
| May 16, 2024 Filed Jul 10, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
GrantClass A ordinary shares | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-022464 · rdgdoc.xml · nonDerivative · entry 3 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,254,999 Read SEC document |
| May 16, 2024 Filed Jul 10, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
GrantClass A ordinary shares | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-022464 · rdgdoc.xml · nonDerivative · entry 2 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,289,999 Read SEC document |
| May 16, 2024 Filed Jul 10, 2024 16:03 UTC |
ARWM Inc Pte. Ltd.10% owner
|
GrantClass A ordinary shares | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-022464 · rdgdoc.xml · nonDerivative · entry 1 ARWM Inc Pte. Ltd. · CIK 0002024269 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,324,999 Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 20:27 UTC |
Cactus Healthcare Management LP10% owner
Cactus Healthcare Management LLC10% owner
|
SaleWarrants to purchase Class A ordinary shares · Derivative | 3,893,334 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001213900-24-017449 · ownership.xml · derivative · entry 2 Cactus Healthcare Management LP · CIK 0001918110 · 10% owner Cactus Healthcare Management LLC · CIK 0001918130 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973,333 Underlying: Class A ordinary shares · 3,893,334 shares Expires not disclosed F1 · kind: The transaction reported herein consists of the private sale by Cactus Healthcare Management LP of (i) 2,530,000 founders shares (consisting of 2,529,999 Class A ordinary shares and one Class B ordinary share which may be converted into a Class A ordinary share upon election by the holder thereof, and therefore treated for purposes hereof as a Class A ordinary share) and (ii) 3,893,334 warrants to purchase Class A ordinary shares. F2 · price: The aggregate sales price received by the reporting persons for all securities sold in the transaction (the founders shares and the warrants) reported herein was $1.00, which is an effective price of less than $0.00 (i) per share and (ii) per warrant. F4 · derivative.exercise_date: The warrants become exercisable 30 days after the Issuer completes its initial business combination (which date is not known currently). F5 · derivative.expiration_date: The warrants expire on the 5th year anniversary of the Issuer's initial business combination (which date is not known currently). F3 · ownership.direct: The securities reported in this row are held of record by Cactus Healthcare Management LP (the "Cactus sponsor"). Cactus Healthcare Management LLC (the "Cactus sponsor GP") serves as the sole general partner of the Cactus sponsor and directs voting and investment decisions made by the Cactus sponsor with respect to the subject shares. The Cactus sponsor GP is owned equally by Hibotan LLC (an affiliate of Israel Biotech Fund), Kalistcare Limited (an affiliate of Consensus Business Group) and Clal Biotechnology Industries Cactus Ltd. (an affiliate of Clal Biotechnology Industries Ltd.), each of which holds a 33.33% equity interest in the Cactus sponsor GP. The Cactus sponsor GP does not possess a pecuniary interest with respect to the subject shares and therefore disclaims beneficial ownership thereof. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 20:27 UTC |
Cactus Healthcare Management LP10% owner
Cactus Healthcare Management LLC10% owner
|
SaleClass A ordinary shares | 2,530,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-017449 · ownership.xml · nonDerivative · entry 1 Cactus Healthcare Management LP · CIK 0001918110 · 10% owner Cactus Healthcare Management LLC · CIK 0001918130 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 632,501 F1 · kind: The transaction reported herein consists of the private sale by Cactus Healthcare Management LP of (i) 2,530,000 founders shares (consisting of 2,529,999 Class A ordinary shares and one Class B ordinary share which may be converted into a Class A ordinary share upon election by the holder thereof, and therefore treated for purposes hereof as a Class A ordinary share) and (ii) 3,893,334 warrants to purchase Class A ordinary shares. F2 · price: The aggregate sales price received by the reporting persons for all securities sold in the transaction (the founders shares and the warrants) reported herein was $1.00, which is an effective price of less than $0.00 (i) per share and (ii) per warrant. F3 · ownership.direct: The securities reported in this row are held of record by Cactus Healthcare Management LP (the "Cactus sponsor"). Cactus Healthcare Management LLC (the "Cactus sponsor GP") serves as the sole general partner of the Cactus sponsor and directs voting and investment decisions made by the Cactus sponsor with respect to the subject shares. The Cactus sponsor GP is owned equally by Hibotan LLC (an affiliate of Israel Biotech Fund), Kalistcare Limited (an affiliate of Consensus Business Group) and Clal Biotechnology Industries Cactus Ltd. (an affiliate of Clal Biotechnology Industries Ltd.), each of which holds a 33.33% equity interest in the Cactus sponsor GP. The Cactus sponsor GP does not possess a pecuniary interest with respect to the subject shares and therefore disclaims beneficial ownership thereof. Read SEC document |
| July 10, 2023 Filed Jul 10, 2023 22:15 UTC |
Kepos Capital LP10% owner
|
SaleClass A Ordinary Shares, par value $0.0001 per share | 250,000 | $10.58 | $2,645,050.00 |
DisclosureSEC source: 0000902664-23-003895 · ownership.xml · nonDerivative · entry 1 Kepos Capital LP · CIK 0001512020 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: The securities to which this filing relates are held directly by certain funds (the "Kepos Funds") to which Kepos Capital LP (the "Investment Manager"), a Delaware limited partnership, serves as investment manager. Mr. Mark Carhart ("Mr. Carhart") is the managing member of Kepos Capital GP LLC, the general partner of the Investment Manager. The Investment Manager and Mr. Carhart disclaim beneficial ownership of the Issuer's securities reported herein except to the extent of its or his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.